Alzamend Neuro Inc Share Price Today: Live Updates & Key Insights

Alzamend Neuro Inc share price today is $1.78, up -3.17%. The stock opened at $1.86 against the previous close of $1.89, with an intraday high of $1.88 and low of $1.71.

Alzamend Neuro Inc Share Price Chart

Alzamend Neuro Inc

us-stock
To Invest in {{usstockname}}
us-stock

Alzamend Neuro Inc Share Price Performance

$1.78 -0.0317(-3.17%) ALZN at 23 Mar 2026 11:58 AM Biotechnology
Lowest Today 1.71
Highest Today 1.88
Today’s Open 1.86
Prev. Close 1.89
52 Week High 10.17
52 Week Low 1.58
Day’s Range: Low 1.71 High 1.88
52-Week Range: Low 1.58 High 10.17
1 day return -
1 Week return -14.15
1 month return -14.15
3 month return -13.53
6 month return -22.88
1 year return +78.43
3 year return -72.32
5 year return -99.09
10 year return -

Alzamend Neuro Inc Institutional Holdings

DRW Securities, LLC 2.40

Geode Capital Management, LLC 0.72

Fidelity Extended Market Index 0.65

Vanguard Group Inc 0.57

Hartland & Co 0.26

Tower Research Capital LLC 0.05

UBS Group AG 0.05

Spartan Total Market Index Pool G 0.05

Fidelity Series Total Market Index 0.02

Vanguard Institutional Extnd Mkt Idx Tr 0.02

BlackRock Inc 0.01

NT Ext Equity Mkt Idx Fd - NL 0.00

Bank of America Corp 0.00

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

BNYM Mellon SL Market Completion UC1 0.00

SBI Securities Co Ltd 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

Activest Wealth Management 0.00

Citigroup Inc 0.00

HARBOR INVESTMENT ADVISORY, LLC 0.00

Alzamend Neuro Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Alzamend Neuro Inc Fundamentals

Market Cap 6.96 M

PB Ratio 3.1699

PE Ratio 0.0

Enterprise Value 6.85 M

Total Assets 4.60 M

Volume 123534

Alzamend Neuro Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:-50740 -0.1M, FY24:-50740 -0.1M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:-4514853 -4.5M, FY24:-9947746 -9.9M, FY23:-14878167 -14.9M, FY22:-12404583 -12.4M, FY21:-5203664 -5.2M

Quarterly Revenue Q1/2026:0 0.0M, Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M

Quarterly Profit Q1/2026:-27685 -0.0M, Q4/2025:-27685 -0.0M, Q3/2025:-27685 -0.0M, Q2/2025:-12685 -0.0M, Q1/2025:-12685 -0.0M

Quarterly Net worth Q1/2026:-2198991 -2.2M, Q4/2025:-1000758 -1.0M, Q3/2025:-2702684 -2.7M, Q2/2025:-1139445 -1.1M, Q1/2025:-1039000 -1.0M

About Alzamend Neuro Inc & investment objective

Company Information Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Organisation Biotechnology

Employees 4

Industry Biotechnology

CEO Mr. Stephan Jackman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Alzamend Neuro Inc FAQs

What is the share price of Alzamend Neuro Inc today?

The current share price of Alzamend Neuro Inc is $1.78.

Can I buy Alzamend Neuro Inc shares in India?

Yes, Indian investors can buy Alzamend Neuro Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Alzamend Neuro Inc shares in India?

You can easily invest in Alzamend Neuro Inc shares from India by:

Can I buy fractional shares of Alzamend Neuro Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Alzamend Neuro Inc?

Alzamend Neuro Inc has a market cap of $6.96 M.

In which sector does Alzamend Neuro Inc belong?

Alzamend Neuro Inc operates in the Biotechnology sector.

What documents are required to invest in Alzamend Neuro Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Alzamend Neuro Inc?

The PE ratio of Alzamend Neuro Inc is N/A and the PB ratio is 3.17.